Refametinib (R enantiomer)
Based on 1 publication(s) in Google Scholar
Refametinib R enantiomer is a MEK inhibitor extracted from patent WO2007014011A2, compound 1022, has an EC50 of 2.0-15 nM.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 923032-38-6
- Formule: C19H20F3IN2O5S
- Masse moléculaire:572.34
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-50706
SelumetinibMEK1/2 Inhibitor -
HY-13064
CobimetinibMEK1 Inhibitor -
HY-13449
TAK-733MEK Inhibitor -
HY-14691
RefametinibMEK1/MEK2 Inhibitor -
HY-12028
PD98059MEK Inhibitor -
HY-10999
TrametinibMEK Inhibitor -
HY-12042
PimasertibMEK1/2 Inhibitor -
HY-14719
RO4987655MEK Inhibitor -
HY-15437
SL327MEK Inhibitor -
HY-12062
PD318088MEK1/2 Inhibitor -
HY-10999A
Trametinib (DMSO solvate)MEK Inhibitor -
HY-12031
U0126-EtOHMEK1/2 Inhibitor
Publications Citing Use of MedChemExpress (MCE) Refametinib (R enantiomer)
MoreVoir tous les produits spécifiques à Isoform MEK
More
Activité biologique
Description
IC50 & Target
[1]|
MEK 2-15 nM (EC50) |
In Vitro
Refametinib R enantiomer is the R enantiomer of Refametinib . Refametinib R enantiomer is an inhibitor of MEK and is useful in treatment of cancer and other hyperproliferative diseases[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 923032-38-6
-
Masse moléculaire 572.34
-
Formule C19H20F3IN2O5S
-
SMILES
O=S(C1(C[C@H](CO)O)CC1)(NC(C(NC(C(F)=C2)=CC=C2I)=C3F)=C(OC)C=C3F)=O
-
Synonyms
BAY 869766 R enantiomer; RDEA119 R enantiomer
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Sci Adv
BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS. [Abstract]2019 Aug 14;5(8):eaav8463. PMID: 31453322
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Refametinib (R enantiomer) Related Classifications
HY-10216 Related Classifications
Powered by Bioz